IQ Consortium Member Companies


Membership in IQ is open to any corporation and/or any subsidiary thereof which is significantly engaged in the development of new chemical entities or new molecular entities for the prevention, diagnosis or treatment of disease. For information about joining the Consortium, please see Join IQ.

Current IQ Consortium members include:

AbbVie

Agios

Alnylam

Amgen, Inc.

Astellas 

AstraZeneca 

Bayer HealthCare

BeiGene

Bill & Melinda Gates
MRI

Biogen

Blueprint Medicines

Boehringer Ingelheim

Bristol Myers Squibb 

CSL Behring

Daiichi Sankyo

Eisai, Inc.

   

Eli Lilly and Company

EMD Serono

Erasca, Inc.

F. Hoffmann-La Roche

Genentech

Gilead Sciences

GSK PLC

Idorsia

Incyte Corporation

Janssen

Merck & Co., Inc.

Mitsubishi Tanabe

Moderna Therapeutics   

Novartis       

Novo Nordisk

Organon

 

Orion

Otsuka 

Pfizer

Regeneron

Relay Therapeutics

Sanofi

Sarepta

Seagen

Servier

Sunovion

Takeda

Teva

UCB Pharma

Vertex, Inc.

Xencor